These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7805990)

  • 21. Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: analysis by menopausal status.
    McGonigle KF; Lantry SA; Odom-Maryon TL; Chai A; Vasilev SA; Simpson JF
    Cancer Lett; 1996 Mar; 101(1):59-66. PubMed ID: 8625283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen and giant endometrial polyp.
    Erdemoglu E; Güney M; Keskin B; Mungan T
    Eur J Gynaecol Oncol; 2008; 29(2):198-9. PubMed ID: 18459567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients.
    Cohen I; Perel E; Tepper R; Flex D; Figer A; Shapira J; Altaras MM; Fishman A; Bernheim J; Cordoba M; Yigael D; Beyth Y
    Breast Cancer Res Treat; 1999 Feb; 53(3):255-62. PubMed ID: 10369071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.
    Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
    Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
    Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.
    Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM
    J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Benign endometrial lesions induced by tamoxifen].
    De Muylder X
    J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):420-4. PubMed ID: 10566160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps: comparison with postmenopausal polyps.
    Altaner S; Gucer F; Tokatli F; Guresci S; Ozdemir C; Puyan FO; Kutlu K
    Onkologie; 2006 Sep; 29(8-9):376-80. PubMed ID: 16974115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD; Aydin Y; Atis A; Mandiraci G
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal manipulation and gynaecological cancer: the tamoxifen dilemma.
    Ross D; Whitehead M
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):63-8. PubMed ID: 7742519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of MRI in symptomatic patients treated with tamoxifen].
    Taïeb S; Ceugnart L; Chevalier A; Cabaret V; Leblanc E; Fournier C; Besson P
    J Radiol; 2003 Jan; 84(1):33-9. PubMed ID: 12637885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.
    Houghton JP; Ioffe OB; Silverberg SG; McGrady B; McCluggage WG
    Mod Pathol; 2003 Apr; 16(4):395-8. PubMed ID: 12692205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Some specifics of tamoxifen's effect on the endometrium in menopausal cancer patients].
    Ashtrafian LA; Antonova IB; Chazova NL; Motskobili TA; Babaeva NA; Al'ditskiĭ IA
    Vopr Onkol; 2005; 51(2):200-5. PubMed ID: 16223001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tamoxifen and endometrial disease in patients with breast cancer].
    Dalbert DB; Rodríguez de la Peña MM; Figueredo A; Mural J; Bartt O; Subiela R; Rossi C; Bazán G
    Medicina (B Aires); 2013; 73(2):97-103. PubMed ID: 23570756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
    Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of tamoxifen on the uterus.
    Ismail SM
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):27-31. PubMed ID: 8777254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of granulosa-cell tumor of the ovary combined with leiomyoma, an endometrial polyp and glandular hyperplasia of the endometrium].
    Grozdanov G; Delev P
    Akush Ginekol (Sofiia); 1989; 28(3):75-6. PubMed ID: 2802087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.